80%Confidence
0Views
FDASource
2026-03-21Date
Summary
Rising Pharma's Temozolomide Capsules recall due to stability testing failures indicates potential quality issues with this important oncology medication manufactured in Taiwan. This could disrupt cancer treatment regimens and prompt increased testing requirements for Rising's other products.
Actionable: Review stability data for all Rising Pharmaceuticals products and establish contingency plans for critical oncology medications.
AI Confidence: 80%
Data Points
firmRising Pharma Holding, Inc.
classificationClass II
statusOngoing
distributionNationwide within the U.S
productProduct label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc., Allendale, NJ 07401
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now